François Paris Selected Research

François Paris Research Topics

Disease

30	Neoplasms (Cancer) 01/2023 - 02/2007
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2013
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2016
5	Hypoxia (Hypoxemia) 01/2020 - 01/2013
4	Glioma (Gliomas) 01/2020 - 03/2015
3	Neuroblastoma 01/2022 - 01/2011
2	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2022
2	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2016
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 05/2005
2	medullary Thyroid cancer 04/2010 - 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Fatigue 12/2022
1	Erythema 10/2022
1	Obesity 10/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Lung Diseases (Lung Disease) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Intestinal Failure 01/2020
1	Vascular Remodeling 10/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2017
1	Premature Aging 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Pain (Aches) 01/2014
1	Hyperalgesia 01/2014
1	Carcinoma (Carcinomatosis) 11/2010
1	Fibrosarcoma 11/2010
1	Carcinogenesis 11/2010
1	Thrombocytopenia (Thrombopenia) 04/2010
1	Leukopenia 04/2010
1	Weight Loss (Weight Reduction) 02/2010
1	Cytopenia 02/2010

Drug/Important Bio-Agent (IBA)

11	Monoclonal AntibodiesIBA 01/2022 - 09/2007
4	GD2 gangliosideIBA 01/2020 - 09/2007
4	AntigensIBA 01/2017 - 09/2007
3	CeramidesIBA 01/2020 - 02/2007
3	O-acetyl-GD2 gangliosideIBA 01/2017 - 01/2011
2	EnzymesIBA 01/2022 - 01/2017
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2020 - 01/2013
2	DesminIBA 01/2020 - 01/2013
2	dinutuximabIBA 01/2017 - 01/2014
2	DNA-Activated Protein KinaseIBA 05/2016 - 01/2016
2	globotriaosylceramide (globotriosylceramide)IBA 04/2013 - 01/2012
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2010 - 02/2010
2	Carcinoembryonic AntigenIBA 04/2010 - 02/2010
1	taxaneIBA 10/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2021
1	AcidsIBA 01/2021
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2020
1	pimonidazoleIBA 01/2020
1	SphingolipidsIBA 01/2020
1	CarbonIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	NestinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	fluoromisonidazoleIBA 02/2018
1	respiratory complex IIIBA 01/2017
1	GlycolipidsIBA 01/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2017
1	GangliosidesIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 07/2016
1	Kruppel-Like Factor 4IBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 07/2016
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Dinoprostone (PGE2)FDA Link 03/2015
1	Epidermal Growth Factor (EGF)IBA 03/2015
1	AntibodiesIBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2013
1	dactolisibIBA 01/2013
1	MethylcholanthreneIBA 11/2010
1	3- mercapto- 3,3- cyclopentamethylenepropionic acidIBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	Type 2 Angiotensin ReceptorIBA 11/2010
1	Growth InhibitorsIBA 04/2010
1	Thalidomide (Thalomid)FDA Link 04/2010
1	Angiogenesis InhibitorsIBA 04/2010
1	Iodine-131IBA 02/2010
1	Bevacizumab (Avastin)FDA Link 02/2010

Therapy/Procedure

12	Radiotherapy 01/2023 - 01/2013
8	Immunotherapy 01/2023 - 09/2007
5	Therapeutics 01/2022 - 04/2010
2	Aftercare (After-Treatment) 01/2023 - 12/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 10/2019
2	Radioimmunotherapy 04/2010 - 02/2010
1	Antineoplastic Protocols 01/2023
1	Subcutaneous Injections 01/2020